Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights)

Business Data, Corporate Office and Headquarter Address

About

Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights) is Buildings and Property in United States that focus on eye disease business. They cover business area such as exclusive right.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

Eye Disease

Website

-

Corporate Office and Headquarter Office address:

280 South Magnum Street
Suite 350
Durham, NC 27701
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

exclusive right

* We use standard office opening hours in near Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights) Frequently Asked Questions

What or who is Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights)?

Atsena Therapeutics (Gene Therapy GUCY2D Exclusive Rights) is Buildings and Property business from United States that founded in - ( years old in ), Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights) business is focusing on Eye Disease.

Where is Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights) headquarter and corporate office address?

Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights) headquarter office and corporate office address is located in 280 South Magnum Street Suite 350 Durham, NC 27701 United States.

Where is Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights) country origins?

Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights) was founded in United States.

What is Eye Disease business focus on?

In , Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights) is currently focus on eye disease sector.

Disclaimer: This website is not affiliated with Atsena Therapeutics (Gene Therapy GUCY2D exclusive rights), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.